Title: Bad Blood Pdf Secrets and Lies in a Silicon Valley Startup
Author: John Carreyrou
Published Date: 2019-03-26
Page: 352
“A great and at times almost unbelievable story. . . . Theranos may be the biggest case of corporate fraud since Enron.” —New York “Chilling. . . . Reads like a thriller. . . . Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review “Gripping. . . . Riveting. . . . [Told] with a momentum worthy of a crime novel.” —Los Angeles Review of Books “Riveting. . . . For all its boomtime feel, there are timeless aspects to Theranos’ story. Venality is age-old, but so is courage, and that of the ex-employees who blew the whistle on its deceptions is restorative. . . . And more than an honorable mention should go to Carreyrou, a dogged old-school reporter uncowed by Theranos’ legal hardball.” —San Francisco Chronicle “Engrossing. . . . Hard to put down. . . . Boasts movie-scene detail. . . . Theranos employees are the story’s heroes, with the force of journalism not far behind.” —Science “A veritable page-turning. . . . Gripping. . . . Presents comprehensive evidence of the fraud perpetrated by Theranos chief executive Elizabeth Holmes... Unveils many dark secrets of Theranos that have not previously been laid bare.” —Nature “This is a ‘stay up all night to read’ book that is just as propulsive, shocking, and riveting as the best thriller novels.” —Bustle “I found myself unable to put it down once I started. This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion.” —Bill Gates, “Five Books I Loved in 2018”“Riveting. . . . Compelling. . . . [Carreyrou’s] unmasking of Theranos is a tale of David and Goliath.” —Financial Times“A fascinating true story that reads like a suspense novel. . . . A telling parable of Silicon Valley magical thinking.” —Selby Drummond, Vogue “In Bad Blood, Carreyrou tells the full, gripping tale of how he slayed the ‘unicorn’ in a fascinating look at how buzz and billions can blind people to facts.” —Marie Claire “This is a ‘stay up all night to read’ book that is just as propulsive, shocking, and riveting as the best thriller novels.” —Bustle “A parable about Silicon Valley delusion. . . . Gossipy fun comes from seeing which high-profile man (James Mattis, Joe Biden) gets drawn into Holmes’ scammy web next.” —Elle “A thorough and devastating piece of reporting that deserves a place alongside the masterworks of the inside-the-boardroom business genre. . . . He quietly compiles detail after damning detail into a fascinating narrative.” —The Weekly Standard “Masterfully reported.” —Bethany McLean, bestselling coauthor of All the Devils Are Here John Carreyrou is a two-time Pulitzer Prize–winning investigative reporter at the Wall Street Journal. For his extensive coverage of Theranos, Carreyrou was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism in the category of beat reporting, and the Barlett & Steele Silver Award for Investigative Business Journalism. Bad Blood was named the Financial Times & McKinsey Business Book of the Year. Carreyrou lives in Brooklyn, New York, with his wife and three children.
A New York Times Notable Book
A Washington Post Notable Book
One of the Best Books of the Year: NPR, San Francisco Chronicle, Time, Esquire, Fortune, Marie Claire, GQ, Mental Floss, Science Friday, Bloomberg, Popular Mechanics, BookRiot, The Seattle Times, The Oregonian, Publishers Weekly, Library Journal
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.
Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron—a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Impossibly too good to be true This is an impeccably researched and referenced account of the Theranos saga. As a long-time observer and sometime competitor of Theranos I watched this tale unfold whilst working at a couple of established IVD companies. Everyone I knew who had ever developed an assay or instrument knew this was smoke and mirrors, impossibly too good to be true. What I never suspected was just how personally dishonest EH had been, and for how long the complex deception was maintained. Whilst I've met a few egregious individuals working for big companies, there are enough checks and balances (QA/RA, Med/Sci Affairs, CLSs and other professionals etc) in place to stop harmful devices getting out the door.The subject matter - developing devices and assays - is a complex dry topic, difficult to write engagingly about. But JC does a workmanlike job and I read this in one go after its midnight Kindle release. My only nit to pick is the poor editing: there are so many uses of '....named....' as in 'an engineer named John Smith' or 'a restaurant named Joe's Bar' that it got irritating. Find/replace 'named' with a comma would have worked fine in most cases. The text was also repetitive - eg '...an award named after Channing...' gets at least 2 mentions. But not enough to lose a star.Kudos to the good people at Theranos who had the courage to get the story out and for JCs persistence into a headwind of legalistic intimidation. I've heard Theranos is now a case-study for MBA students: this book should be required reading for anyone thinking about 'disrupting' the medical devices industry. There are lives at stake.I wish I could give this book 10 stars It takes a mighty strong person and an incredible investigative journalist to take down a multibillion company lead by a CEO and her partner who are doing nothing but telling lies, mistreating their employees, taking millions of dollars under false pretenses from Fortune 500 businesses and wealthy investors, betraying their esteemed board members, and worst and most harmful of all, putting the lives of their end customers in serious jeopardy because the technology that they claim to have engineered does not exist nor has it been FDA approved or tested. This is John Carreyrou’s BAD BLOOD: SECRETS AND LIES IN A SILICON VALLEY STARTUP. Carreyrou went to monumental lengths over the course of several years, with the help of named and unnamed sources who worked or were connected to Theranos, the company, which claimed to have created a blood-testing device that with ‘one drop of blood’ could obtain hundreds of test results thus saving lives. Not only were their little machines ineffective but they were doing no such thing. Meaning, they could not provide accurate test results because they were not even obtaining them. Rather, they were using commercial analyzers in their place. At the helm was Theranos founder and CEO Elizabeth Holmes, a Stanford drop-out who had a brilliant idea, but it was never brought to fruition. She simply leads people to believe it was with her charm. A lot of people.It is staggering how many people she swayed. We’re not just talking about a co-worker or two but former heads of state, who later joined her board, people who amassed fortunes in the billions who were willing to loan Theranos money, major corporations including Walgreens and Safeway who wanted to get in on the ground floor, and many more. It is equally astonishing how so many smart, successful people were not taken aback by her freakish obsession with imitating Steve Jobs. Perhaps, they chalked this up to her eccentricity.It took courage for people to come forward. They were threatened with lawsuits that could bankrupt them ten times over, by one of the leading and most intimidating litigators in the country. Carreyrou, a Pulitzer Prize winning investigative journalist, who has been with The Wall Street Journal for almost 10 years, had the support of his editor, newspaper, and its attorneys. He never thought for a minute to back down. The result – a series of articles in the paper that exposed Theranos and Holmes for the fraud they committed.It is dumbfounding to read BAD BLOOD and to think that Holmes and her number two in command, Sunny Balwani, also her romantic partner, which was kept secret, got away with so much for so long, and even when finally confronted and their hands were forced, they still would not admit fault. Is Holmes a criminal? Is she delusional?What I do know is that you will not be able to put this book down.
Brotopia pdf
Emotional Intelligence 2 pdf
Big Things Have Small Beginnings pdf
The New SES Application 2nd Ed pdf
Principles pdf
When Friday Isn& pdf
Beyond the Wisdom of Walt pdf
The One-Minute Gratitude Journal pdf
Summary & pdf
Upgrade Yourself pdf
Valley Speak pdf
The Passive Income Playbook pdf
A Spy& pdf
Stock Market & pdf
Making Business Connections That Count pdf
Get Paid TODAY! pdf
Tags: 0525431993 pdf,Bad Blood pdf,Secrets and Lies in a Silicon Valley Startup pdf,John Carreyrou,Bad Blood: Secrets and Lies in a Silicon Valley Startup,Vintage,0525431993,BUSINESS & ECONOMICS / Corporate Finance / Venture Capital,BUSINESS & ECONOMICS / Entrepreneurship,Business & Economics/Corporate Finance - Venture Capital,Business & Economics/Finance - General,Business & Economics/Infrastructure,Business/Economics,GENERAL,General Adult,HISTORY OF SPECIFIC COMPANIES,Non-Fiction,TECHNOLOGY & ENGINEERING / Biomedical,Technology & Engineering/Biomedical,United States,WHITE COLLAR CRIME,true crime books;medical books;theranos;best books of 2018;best books 2018;best books on amazon;amazon best books;books best sellers;nonfiction best sellers 2018;venture capital;top books 2018 best seller;non fiction;new york time best sellers;nonfiction books;top rated books;bestselling book;non fiction best sellers list;startup;best sellers list new york times 2018;best sellers list new york times;new york times best sellers;finance books;true crime;business books;business;silicon valley,venture capital; top books 2018 best seller; non fiction; new york time best sellers; nonfiction books; top rated books; bestselling book; non fiction best sellers list; startup; best sellers list new york times 2018; best sellers list new york times; new york times best sellers; finance books; true crime; business books; business; silicon valley; books best sellers; nonfiction best sellers 2018; best books of 2018; best books 2018; best books on amazon; amazon best books; medical books; theranos; true crime books
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.